Using this technique, Kariolis et al. showed that an ATV against BACE1 markedly reduced brain Aβ levels compared to the parental BACE1 antibody in a model of Alzheimer’s disease as well as in non-human primates [41]. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.